Emami Limited Schedules Investor Conference Call on 21 May 2026 Post Q4 FY26 Results
Emami Limited has scheduled a conference call with analysts and investors on 21 May 2026 at 4:00 PM IST, following the announcement of its Q4 FY26 financial results. The call will be attended by senior management including the Wholetime Director & Vice Chairman, Mr. Mohan Goenka, along with heads of international business, growth, healthcare, sales, and finance. The intimation was filed on 14 May 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dial-in access has been provided for participants in India, the USA, UK, Singapore, and Hong Kong.
*this image is generated using AI for illustrative purposes only.
Emami Limited has announced a conference call with analysts and investors scheduled for Thursday, 21 May 2026 at 4:00 PM IST, to be held following the declaration of the company's Q4 FY26 financial results. The intimation was filed by the Company Secretary & Compliance Officer, Ravi Varma, on 14 May 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details of the call are also available on the company's official website.
Management Participants
The conference call will feature participation from a broad cross-section of Emami's senior leadership team, covering key functional areas including international business, growth, healthcare, sales, and finance. The following management representatives are scheduled to participate:
| Role: | Name |
|---|---|
| Wholetime Director & Vice Chairman | Mr. Mohan Goenka |
| CEO (International Business) | Mr. Vivek Dhir |
| Chief Growth Officer | Mr. Dhruv Aggarwal |
| President (Healthcare) | Mr. Gul Raj Bhatia |
| President (Sales) | Mr. Manish Gupta |
| President (Finance & IR) | Mr. Rajesh Sharma |
Conference Call Details
The call is open to participants across multiple geographies, with dial-in numbers provided for India and select international locations. The following table summarises the key logistical details:
| Parameter: | Details |
|---|---|
| Date & Time (IST) | Thursday, 21 May 2026, 4:00 PM |
| Hong Kong / Singapore | 6:30 PM |
| UK | 11:30 AM |
| New York | 6:30 AM |
| India – Universal Access | +91 22 6280 1259 / +91 22 7115 8160 |
| USA (Toll-free) | 18667462133 |
| UK (Toll-free) | 08081011573 |
| Singapore (Toll-free) | 8001012045 |
| Hong Kong (Toll-free) | 800964448 |
Further Information
For additional details regarding the conference call, participants may contact the following representatives:
- Percy Panthaki | Tel: +91 91679 97661 | Email: percy.panthaki@iiflcap.com
- Siddhesh Deshmukh | Tel: +91 97660 45690 | Email: siddhesh.deshmukh@iiflcap.com
The full schedule of investor calls is also accessible through Emami's investor relations section at the company's official website.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.84% | -5.80% | +0.97% | -17.74% | -33.04% | -14.35% |
How might Emami's Q4 FY26 results reflect the impact of rural consumption recovery and premiumization trends on its core product categories?
What strategic updates could Emami's international business leadership signal regarding expansion plans in emerging markets like MENA, SAARC, or Africa?
How is Emami positioned to navigate rising input costs for key raw materials like menthol and herbal ingredients in FY27?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
